[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354124-105":59,"doc-detail-354124-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","simvastatin-restores-cisplatin-sensitivity-by-suppressing-the-caveolin-1-mediated-pi3kakt-signaling-pathway-in-cisplatin-resistant-cervical-cancer-cells","Simvastatin Restores Cisplatin Sensitivity by Suppressing the Caveolin-1-Mediated PI3K/AKT Signaling Pathway in Cisplatin-Resistant Cervical Cancer Cells","","Cervical cancer treatment is frequently limited by cisplatin (DDP) resistance, while statins have been reported to provide anti-tumor effects and potential chemosensitization beyond cholesterol lowering. This study evaluated seven statins on cisplatin-resistant cervical cancer cells and parental controls using CCK-8 assays. Simvastatin notably restored cisplatin sensitivity, inhibited viability and migration, and promoted apoptosis. Mechanistically, simvastatin suppressed CAV1, PI3K, and p-AKT, with CAV1 knockdown increasing chemosensitivity and CAV1 overexpression partially reversing effects, confirmed in vivo by reduced tumor growth and Ki67 staining.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/simvastatin-restores-cisplatin-sensitivity-by-suppressing-the-caveolin-1-mediated-pi3kakt-signaling-pathway-in-cisplatin-resistant-cervical-cancer-cells/354124/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/simvastatin-restores-cisplatin-sensitivity-by-suppressing-the-caveolin-1-mediated-pi3kakt-signaling-pathway-in-cisplatin-resistant-cervical-cancer-cells/354124.png","ImageObject",300,407,{"name":92,"@type":93},"Aditya","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is cisplatin resistance a major challenge in cervical cancer treatment?","Question",{"text":112,"@type":113},"Cisplatin resistance often develops after prolonged exposure, driving tumor recurrence and metastasis and ultimately worsening prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What was the main experimental finding about simvastatin in cisplatin-resistant cervical cancer cells?",{"text":117,"@type":113},"Simvastatin restored cisplatin sensitivity, showing synergistic anti-cancer effects by reducing cell viability and migration while increasing apoptosis.",{"name":119,"@type":110,"acceptedAnswer":120},"How does simvastatin restore cisplatin sensitivity according to the mechanistic results?",{"text":121,"@type":113},"Simvastatin downregulated caveolin-1 (CAV1) and reduced PI3K and p-AKT protein expressions, and CAV1 knockdown increased cisplatin sensitivity; CAV1 overexpression partially counteracted simvastatin’s inhibitory effects.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354124,1790694621,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","The FASEB Journal  \nRESEARCH ARTICLE  OPEN ACCESS   \nSimvastatin Restores Cisplatin Sensitivity by Suppressing the Caveolin-1-Mediated PI3K/AKT Signaling Pathway in Cisplatin-Resistant Cervical Cancer Cells  \nYujia Zhou1 | Hejing Liu1 | Shuangjia Pan1 | Luyi Ruan1 | Jiayi Ruan1 | Jiaru Chen2 | Huihui Ji1 | Xueqiong Zhu1   \n1Zhejiang Provincial Clinical Research Center for Gynecological Diseases, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of  \nWenzhou Medical University, Wenzhou, People's Republic of China | 2Alberta Institute, Wenzhou Medical University, Wenzhou, People's Republic of China Correspondence: Huihui Ji ([jihuihui@wmu.edu.cn](jihuihui@wmu.edu.cn)) | Xueqiong Zhu ([zjwzzxq@163.com](zjwzzxq@163.com))  \nReceived: 30 November 2025 | Revised: 27 March 2026 | Accepted: 28 April 2026  \nKeywords: Caveolin-1 | cervical cancer | cisplatin resistance | PI3K/AKT signaling pathway | simvastatin  \nABSTRACT  \nCervical cancer treatment is often hindered by the emergence of cisplatin (DDP) resistance. Increasing evidence has indicated that statins possess anti-tumor and chemosensitization potential beyond their lipid-lowering effects. Statin utilization is found tobe significantly linked to decreased cervical cancer incidence and mortality. However, whether statins affect chemosensitivity tocisplatin in cisplatin-resistant cervical cancer remains to be clarified. In cervical cancer cisplatin-resistant cell lines (SiHa-DDP and C33a-DDP) constructed from their parental cells, the effects of seven statins (simvastatin, fluvastatin, pitavastatin, lovastatin, atorvastatin, rosuvastatin, and pravastatin) on cell viability in cisplatin-resistant cells and corresponding parental cells were assessed using the CCK-8 assay. Compared with parental counterparts, the IC50 values of seven statin drugs were markedly elevated in cells exhibiting cisplatin resistance. Simvastatin significantly enhanced the efficacy of cisplatin in cisplatin-resistant cervical cancer cells, demonstrating a synergistic anti-cancer effect (CI \u003C 1) . Combined therapy using simvastatin and cisplatin inhibited cell viability and migration while promoting cell apoptosis. Mechanistically, simvastatin downregulated protein expressions of caveolin-1 (CAV1), PI3K, and p-AKT. CAV1 knockdown in SiHa-DDP and C33a-DDP cells markedly increased cisplatin sensitivity, confirming its critical role in chemoresistance. Rescue experiments showed that CAV1 overexpression partially counteracted the inhibitory effects of simvastatin. In vivo, compared with monotherapies, simvastatin combined with cisplatin treatment markedly suppressed tumor growth, reduced CAV1 protein expression, decreased the percentage of Ki67-positive cells and promoted apoptosis. In all, simvastatin enhanced cisplatin sensitivity by suppressing the CAV1-mediated PI3K/AKT pathway involvement in the development of cisplatin resistance in cervical cancer cells. These findings reveal a novel mechanism in cervical cancer cells resistant to cisplatin by which simvastatin may serve as a potential adjuvant to improve the therapeutic efficacy of cisplatin-based chemotherapy.  \n1 | Introduction  \nCervical cancer is the fourth most prevalent malignancy in women and remains a significant global health burden, with population-based data indicating an overall 5-year survival  \napproaching 70%[1] . Stage-dependent survival varied markedly among cervical cancer patients from 2000 to 2021. Patients with early-stage disease (FIGO IA) had a favorable prognosis, with a 5-year overall survival of 95.3%, whereas those with advancedstage disease (FIGO IV) experienced substantially poorer  \n\n| Yujia Zhou and Hejing Liu contributed equally to this work. |\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modificat","cbCaiuGEJTpc4PT0","https://ap.wps.com/l/cbCaiuGEJTpc4PT0","pdf",14136489,16,"English","# Abstract\n# Introduction","[{\"question\":\"Why is cisplatin resistance a major challenge in cervical cancer treatment?\",\"answer\":\"Cisplatin resistance often develops after prolonged exposure, driving tumor recurrence and metastasis and ultimately worsening prognosis.\"},{\"question\":\"What was the main experimental finding about simvastatin in cisplatin-resistant cervical cancer cells?\",\"answer\":\"Simvastatin restored cisplatin sensitivity, showing synergistic anti-cancer effects by reducing cell viability and migration while increasing apoptosis.\"},{\"question\":\"How does simvastatin restore cisplatin sensitivity according to the mechanistic results?\",\"answer\":\"Simvastatin downregulated caveolin-1 (CAV1) and reduced PI3K and p-AKT protein expressions, and CAV1 knockdown increased cisplatin sensitivity; CAV1 overexpression partially counteracted simvastatin’s inhibitory effects.\"}]","Simvastatin Restores Cisplatin Sensitivity by Suppressing the Caveolin-1-Mediated PI3K/AKT Signaling Pathway in Cisplatin-Resistant Cervical Cancer Cells | PDF",1790109120,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64bd0285b3540f1486a577713a9c829f.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/756f2d8763b7c390d59fa26a72201265.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca066c438b94d5497bd7bebb4e48f1b2.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/afb076de983c30e1921d68e8b5387432.webp",980,1287]